QNTM
Quantum BioPharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About QNTM
Quantum Biopharma Ltd.
A biopharmaceutical company dedicated to building a portfolio of innovative assets and biotechnology solutions
199 Bay St., Suite 4000, Toronto, Ontario M5L 1A9, Canada
--
Quantum BioPharma Ltd. was established on November 1, 1998. Pursuant to the terms of the amendment, on May 24, 2018, the Company changed its name to "FSD Pharma Inc.". The Company operates two business segments: one focuses on biological sciences, including research and development (" R&D ") and clinical development of synthetic cannabinoid-based treatments for certain diseases, with the aim of improving patient outcomes. Their goal is for these compounds to eventually be approved as prescription drugs by the FDA and other international regulators. Another division focuses on the production and extraction of high-quality hydroponic pharmaceutical-grade cannabis leaves. The common denominator between the two sectors is the medicinal cannabis plant and its derived cannabinoids.
Company Financials
EPS
QNTM has released its 2023 Q3 earnings. EPS was reported at -0.03, versus the expected -0.14, beating expectations. The chart below visualizes how QNTM has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
